Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA RP11‑805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR‑34b‑3p and miR‑139‑5p in lung adenocarcinoma. | Oncol Rep | 2022 | 35866595 | PubTator, text mining | PubMed |
| The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer. | Front Oncol | 2022 | 35860591 | PubTator, text mining | PubMed |
| The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma. | Front Oncol | 2022 | 35860547 | PubTator, text mining | PubMed |
| RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition. | Sci Adv | 2022 | 35857500 | PubTator, text mining | PubMed |
| Advancements in inner ear development, regeneration, and repair through otic organoids. | Curr Opin Genet Dev | 2022 | 35853286 | PubTator, text mining | PubMed |
| TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment. | J Transl Med | 2022 | 35842634 | PubTator, text mining | PubMed |
| RNA-seq reveals co-dysregulated circular RNAs in the adenomyosis eutopic endometrium and endometrial-myometrial interface. | BMC Womens Health | 2022 | 35841021 | PubTator, text mining | PubMed |
| RNANetMotif: Identifying sequence-structure RNA network motifs in RNA-protein binding sites. | PLoS Comput Biol | 2022 | 35819951 | PubTator, text mining | PubMed |
| PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449. | Front Oncol | 2022 | 35814385 | PubTator, text mining | PubMed |
| LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy. | Front Endocrinol (Lausanne) | 2022 | 35813614 | PubTator, text mining | PubMed |
| Engineered exosomes for targeted delivery of miR-187-3p suppress the viability of hemangioma stem cells by targeting Notch signaling. | Ann Transl Med | 2022 | 35813344 | PubTator, text mining | PubMed |
| Effects of Hypoxia on RNA Cargo in Extracellular Vesicles from Human Adipose-Derived Stromal/Stem Cells. | Int J Mol Sci | 2022 | 35806391 | PubTator, text mining | PubMed |
| LIN28 Family in Testis: Control of Cell Renewal, Maturation, Fertility and Aging. | Int J Mol Sci | 2022 | 35806250 | PubTator, text mining | PubMed |
| Triple-Negative Breast Cancer circRNAome Reveals Hsa_circ_0072309 as a Potential Risk Biomarker. | Cancers (Basel) | 2022 | 35805051 | PubTator, text mining | PubMed |
| Regulated dicing of pre-mir-144 via reshaping of its terminal loop. | Nucleic Acids Res | 2022 | 35801921 | PubTator, text mining | PubMed |
| A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview. | J Ovarian Res | 2022 | 35799305 | PubTator, text mining | PubMed |
| Prognostic Characteristics of Immune-Related Genes and the Related Regulatory Axis in Patients With Stage N+M0 Breast Cancer. | Front Oncol | 2022 | 35785160 | PubTator, text mining | PubMed |
| LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression. | Oncogenesis | 2022 | 35780125 | PubTator, text mining | PubMed |
| N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. | Sci Rep | 2022 | 35773310 | PubTator, text mining | PubMed |
| Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma. | BMC Cancer | 2022 | 35768791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=25